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Introduction
In the past few years, because of the need to find 
alternatives to conventional therapies, several in-
vestigations have focused on the beneficial effects 
Background/purpose: It has recently been documented that various probiotic formu-
lations have beneficial effects in reducing caries risk as well as promoting human 
health. The aim of the present study was to examine the efficacy of short-term con-
sumption of a multistrain probiotic-kefir on salivary counts of Streptococcus mutans 
and Lactobacillus spp. in young adults.
Materials and methods: In total, 104 subjects aged 20−27 years were included in 
the study. The salivary flow rate, buffer capacity, salivary mutans streptococci and 
lactobacilli counts were detected in each subject after a 3-week washout period 
using chair-side kits at baseline. Subjects were randomly assigned into three groups: 
Group I consumed 100 mL kefir per day (n = 35); Group II consumed 2 ˜  100 mL kefir 
per day (n = 35); and Group III consumed 100 mL milk (n = 34). A questionnaire investi-
gating the oral and dietary habits of the subjects was also filled out by each subject. 
After 3 weeks of consumption of the experimental materials, salivary mutans strep-
tococci and lactobacilli counts were reevaluated.
Results: Statistically significant reductions were observed in both salivary mutans 
streptococci and lactobacilli in Group II compared to the baseline (P = 0.001 and 
P = 0.01, respectively).
Conclusion: Short-term consumption of kefir might reduce high levels of salivary 
mutans streptococci and lactobacilli.
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of probiotic agents and their possible roles in pre-
venting and treating various diseases.1,2 In addition 
to their general effects on human health, beneficial 
effects in maintaining oral health were also docu-
mented in some studies. Positive correlations were 
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shown to exist for salivary counts of cariogenic bac-
teria with their quantity in the plaque and the conse-
quent risk of developing caries.3−12
Among dairy products containing probiotic bac-
teria, yogurt, cheese, and ice cream are currently 
consumed.3−12 In today’s market, however, other 
alternatives are becoming more popular, such as kefir, 
which is increasingly consumed in many Western 
markets like Austria, Latvia, Turkey, and the US.13 
Kefir is a product of the fermentation of milk with 
grains and mother cultures prepared from grains. 
These grains contain a lactic acid, acetic acid bac-
teria, and yeast mixture coupled together with ca-
sein.14,15 It has specific characteristics, such as taste, 
aroma, and texture, which are attributed to the 
presence of a complex microbial population.16
In the literature, several health-promoting prop-
erties were associated with kefir consumption.17 The 
beneficial action of this fermented milk can be par-
tially attributed to the inhibition of pathogenic mi-
croorganisms by metabolic products such as organic 
acids produced by kefir microflora.18 However, data 
are lacking about the efficacy of kefir on dental car-
ies risk factors. Thus, the aim of the present study 
was to evaluate whether or not the short-term oral 
consumption of kefir  containing multiple bacterial 
strains can change the salivary counts of Streptococcus 
mutans and Lactobacillus spp. in young adults.
Material and methods
Subjects
A total of 104 volunteers (55 females, 49 males) aged 
20−27 years (mean age, 23.50 ± 2.40 years) partici-
pated in the study. The study protocol was approved 
by the Ethics Committee of the School of Medicine, 
Ege University, Izmir, Turkey. All participants were 
healthy and had not used antibiotics within 2 months 
prior to the study. Smokers and subjects who were 
receiving medications or xylitol-containing prod-
ucts, or who were undergoing orthodontic treat-
ments were excluded from the study. None of the 
subjects exhibited active caries lesions or clinical 
signs of either gingivitis or periodontal disease.
Study design
This was a randomized, controlled study with three 
parallel groups: Group I consumed 100 mL kefir per 
day for 3 weeks (n = 35); Group II consumed 2 ˜  100 mL 
kefir per day for 3 weeks (n = 35); and Group III con-
sumed 100 mL milk per day for 3 weeks (n = 34). At 
the beginning of the study, a questionnaire was filled 
out about each subject’s health, medications, den-
tal care practices, and use of lactic acid products. 
Table 1. Composition of kefir used in the study
pH 4.55 ± 0.06
Total solids (%) 7.80 ± 0.55
Acidity (lactic acid %) 0.77 ± 0.05
Milk fat (%) 3.00 ± 0.15
Lactose (%) 3.45 ± 0.20
Protein (%) 3.60 ± 0.15
Lactobacillus spp. (cfu/mL) 3.3 ˜  108
Streptococcus spp. (cfu/mL) 1.7 ˜  109
Subjects were instructed not to use milk products for 
3 weeks (washout) prior to the baseline saliva sam-
pling and during the study. Subjects were also in-
structed to brush their teeth with a fluoride-containing 
toothpaste twice a day. The use of other fluoridated 
products was forbidden.
Composition of kefir
The kefir used in the present study was supplied 
by Sakipaga Co. (Izmir, Turkey). Kefir containing 3.5% 
fat was made by stirring the frozen kefir culture. 
The pH, titratable acidity (expressed as the per-
centage lactic acid), total solids, milk fat, protein, 
and lactose contents were determined according 
to Turkish Standards Institution Methods.19 The com-
position of the kefir is summarized in Table 1. For 
the determination of Streptococcus spp. and Lacto-
bacillus spp. counts, M17 Agar (CM 785; OXOID Ltd., 
Basingstoke, Hampshire, UK) and MRS Agar (CM 361; 
OXOID) were used, respectively.20 The initial number 
of cells was 106−1010 colony-forming units (cfu)/mL 
in Kefir DC500 derived from the Danisco-Biolacta 
Company’s collection (Olsztyn, Poland). The em-
ployed multistrain probiotic inocula contained mi-
croorganisms from Lactococcus lactis spp. lactis, 
Lactococcus lactis spp. cremoris, Lactococcus lactis 
spp. diacetylactis, Leuconostoc mesenteroides spp. 
cremoris, Lactobacillus kefyr, Kliyveromyces marx-
ianus, and Saccharomyces unisporus.21,22
The participants were instructed to actively 
drink kefir and sour milk 10 minutes after breakfast 
(08:00−09:00). In Group II, a second consumption 
was ordered 10 minutes after lunch (12:00−13:00). 
Tooth-brushing was not allowed for at least 1 hour 
after drinking the beverages.
Clinical examination and saliva sampling
A pediatric dentist examined the subjects’ oral 
health before the study. The clinical examination 
was carried out using World Health Organization cri-
teria23 and the numbers of decayed/missing/filled 
surfaces were recorded. Stimulated whole saliva was 
collected from each subject at baseline to measure 
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the salivary flow rate, buffer capacity, and salivary 
counts of mutans streptococci and lactobacilli after 
the 3-week washout period between 09:00 and 11:00 
to minimize circadian rhythm effects. Each partic-
ipant was instructed not to eat or drink for 2 hours 
preceding the sampling procedure. After thoroughly 
rinsing the mouth with water, saliva was collected 
for 5 minutes, directly into a graded test tube. The 
flow rate was immediately measured and the buffer 
capacity was determined using CRT buffer (Ivoclar 
Vivadent AG, Schaan, Principality of Liechtenstein) 
according to the manufacturer’s instructions.
A B
< 105 ≥ 105
Fig. 1 Pictures of colony-forming units show the differences in Streptococcus mutans between Group I (< 105) and 
Group II (≥ 105).
The counts of salivary mutans streptococci and 
lactobacilli were evaluated using CRT bacteria 
(Ivoclar Vivadent AG) in accordance with the man-
ufacturer’s instructions. Briefly, saliva was inocu-
lated on a dip-slide with selective agar media for 
mutans streptococci and lactobacilli. After adding 
a NaHCO3 tablet, the slides were cultivated at 37ºC 
for 48 hours. The cfu density was visually compared 
against a chart provided by the manufacturer (Figs. 1 
and 2). Both salivary mutans streptococci and lacto-
bacilli counts were categorized as Group I (< 105) 
and Group II (≥ 105) according to the cfu density.
BA
< 105 ≥ 105
Fig. 2 Pictures of colony-forming units show the differences in lactobacilli between Group I (< 105) and Group II (≥ 105).
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Table 3. Salivary mutans streptococci and lactobacilli levels after 3 weeks’ consumption of kefir and milk
 Group I, n (%) Group II, n (%) Group III, n (%) P*
Mutans streptococci (cfu/mL)    0.021
 < 105 24 (68.6) 27 (77.2) 23 (67.6)
 ≥ 105 11 (31.4)  8 (22.8) 11 (32.4)
Lactobacilli (cfu/mL)    < 0.001
 < 105 24 (68.6) 27 (77.2) 23 (67.6)
 ≥ 105 11 (31.4)  8 (22.8) 11 (32.4)
*χ2, one-way ANOVA, and Kruskal-Wallis tests.
Table 2. Salivary parameters and the DMFS (decayed/missing/filled surfaces) index at baseline (after the washout 
period)*
 Group I, n (%) Group II, n (%) Group III, n (%) P†
Mutans streptococci (cfu/mL)    0.25
 < 105 17 (48.6) 16 (45.7) 16 (47.0)
 ≥ 105 18 (51.4) 19 (54.3) 18 (53.0)
Lactobacilli (cfu/mL)    0.19
 < 105 24 (68.6) 20 (57.2) 21 (61.7)
 ≥105 11 (31.4) 15 (42.8) 13 (38.3)
Buffer capacity    0.04
 Low 2 (5.7) 0 (0) 1 (2.9)
 Medium 17 (48.6) 11 (31.4) 19 (55.9)
 High 16 (45.7) 24 (68.6) 14 (41.2)
Flow rate (mL/min) 1.77 ± 0.67 1.86 ± 0.72 1.66 ± 0.59 0.45
*The total DMFS score for Groups I, II and III was 5.2 ± 0.5; †χ2, one-way ANOVA, and Kruskal-Wallis tests.
After 3 weeks’ consumption of kefir or milk, sali-
vary mutans streptococci and lactobacilli counts 
were reevaluated.
Statistical analysis
Data were processed with SPSS version 16.0 (SPSS 
Inc., Chicago, IL, USA). Normally distributed numeric 
variables were compared among groups by one-way 
analysis of variance (ANOVA). Variance homogeneity 
was controlled by the Levene test, and when the 
ANOVA result was significant, a post hoc method for 
pairwise comparisons was selected according to 
variance homogeneity. Dunnett’s T3 or Bonferroni’s 
test was used as the post hoc test.
For ordinal variables (S. mutans and lactobacilli), 
Kruskal-Wallis test was used. For significant results, 
pairwise comparisons were made using the Mann-
Whitney U-test.
In order to test changes within a group (S. mutans 
and lactobacilli), the Wilcoxon signed-rank test 
was used.
Results
Baseline data on the subjects’ dental health and 
salivary parameters are given in Table 2. The sali-
vary flow rate was within normal limits among 
the participants in all groups, ranging from 0.9 to 
2.0 mL/min.
Changes in the counts of mutans streptococci and 
lactobacilli after 3 weeks’ consumption of kefir or 
milk are shown in Table 3. Significant reductions 
were found in both salivary mutans streptococci 
and lactobacilli in Group II compared to baseline 
counts and the other groups. There were also de-
creases in Groups I and III, but they were not statis-
tically significant.
Discussion
Interest in the use of probiotics is rapidly growing. 
Probiotics are provided as food items in one of four 
basic ways: (1) as a culture concentrate (fruit juice); 
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(2) inoculated into prebiotic fibers which promote 
the growth of probiotic bacteria; (3) inoculated into 
milk and milk-based foods (milk, yogurt, cheese, 
kefir, and bio-drinks); and (4) as lyophilized, dried 
cells packaged as dietary supplements (tablets, 
chewing gums, and straws).13 Recently, Meurman24 
stated that although dairy foods are considered use-
ful vehicles for probiotic delivery, the best way of 
administration has yet to be identified.
Increasing numbers of different dairy foods con-
taining probiotics are available in the market today. 
Among these, milk, yogurt, cheese and, most re-
cently, ice cream have been the focus of manufac-
turers attempting to elevate the consumption of 
such products.3−12 Kefir, on the other hand, is con-
sidered another archetypical probiotic dairy drink 
that has already achieved a place in today’s market.17 
Although its health-promoting properties are well 
documented, no data exist on the efficacy of kefir 
in modulating dental caries risk factors in the liter-
ature. For this reason, the present study was under-
taken to evaluate the short-term effects of kefir 
consumption on inhibiting the growth of cariogenic 
microorganisms such as mutans streptococci and 
lactobacilli in the saliva.
The potential effects of probiotics in interacting 
with mutans streptococci by reducing the number 
of this cariogenic pathogen have been reported.3−12 
However, an unchanged score for salivary mutans 
streptococci has also been found.7 Because of the 
consumption of lactobacilli, an increased salivary 
count of lactobacilli was noted.7 Despite these in-
consistencies in the literature, the various dairy prod-
ucts containing probiotics have continued to draw 
the attention of researchers to investigate their 
effects on dental caries risk factors with both long- 
and short-term consumption.
In the present study, mutans streptococci and 
lactobacilli counts were significantly reduced after 
3 weeks’ consumption of kefir in Group II (which 
consumed 2 ˜  100 mL kefir per day) compared to 
Groups I and III. The short-term effect of probiotics 
was also supported by the results of Ahola et al.’s 
study,6 in which a probiotic-containing cheese was 
tested.
Näse et al.4 reported that Lactobacillus GG milk 
had beneficial effects on dental caries in young 
children with long-term consumption. However, milk 
is a dairy product that is quickly cleared from the 
oral cavity. Kefir, on the other hand, is a more vis-
cous dairy product than milk that remains for a 
longer time in the oral cavity, and might have an 
effect on salivary microbial counts with short-term 
consumption.
It should also be noted that some strains most 
likely have oral effects without colonizing the oral 
cavity. In the present study, a multistrain probiotic 
(Lactococcus lactis spp. lactis, Lactococcus lactis 
spp. cremoris, Lactococcus lactis spp. diacetylac-
tis, Leuconostoc mesenteroides spp. cremoris, 
Lactobacillus kefyr, Kliyveromyces marxianus, and 
Saccharomyces unisporus) was used to overcome this 
issue. While a monostrain has to overcome barriers 
presented by the host and its endogenous micro-
organisms, multistrain probiotics have a greater 
divergence, and an enhanced chance of survival of 
at least one strain.25
To date, several working mechanisms of probiot-
ics have been proposed, i.e., secretion of various 
antimicrobial substances such as organic acids, hy-
drogen peroxide, and bacteriocins. These substances 
fight against S. mutans strains to replace the natu-
rally occurring cariogenic strains. In addition, they 
compete with pathogenic agents for adhesion sites 
on the mucosa. Probiotics can also change the sur-
rounding environment by modulating the pH and/
or the oxidation−reduction potential, which can com-
promise the ability of pathogens to become estab-
lished. A combination of probiotic strains is often 
used to increase these beneficial effects. Kefir is 
a multistrain probiotic that might have combined 
potential effects on salivary mutans streptococcus 
and lactobacilli as discussed above. It appears that 
kefir has a potential effect in changing the home-
ostasis of the oral ecosystem leading to the prolif-
eration of a bacterial film. In addition, its viscous 
composition might help it adhere to dental sur-
faces and more easily integrate into the bacterial 
communities.26
In conclusion, it is suggested that short-term con-
sumption of kefir might inhibit the growth of high 
levels of salivary mutans streptococci and lactoba-
cilli. It is also noteworthy to underline the fact that 
this study was carried out on young adults. It would 
also be interesting to see the effect of short-term 
consumption of kefir on young children since their 
immature microflora may be even more easily af-
fected than that of adults, and therefore might eas-
ily inhibit the growth of cariogenic microorganisms 
in a most interesting target group: caries-prone chil-
dren. Further studies with larger numbers of subjects 
should be carried out to confirm these results.
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